Chemotherapy Treatment Market
Chemotherapy Treatment Market Forecasts to 2030 - Global Analysis By Drug (Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Alkylating Agents, Mitotic Inhibitors, Antimetabolites and Other Drugs), Route of Drug, Dose, End User and By Geography
According to Stratistics MRC, the Global Chemotherapy Market is accounted for $8.81 billion in 2023 and is expected to reach $16.62 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Chemotherapy is a medical procedure that uses medications to either eliminate or slow the development of cancer cells in the body. It is a typical method of treating cancer and may be used alone or in combination with other treatments including surgery, radiation therapy, or immunotherapy. Chemotherapy medications target cells that divide quickly, including both cancer cells and some healthy cells. Unfortunately, as normal, healthy cells are also impacted by the treatment, this can result in a number of negative side effects, including nausea, hair loss, exhaustion, and a weaker immune system.
According to data from 2021 provided by the International Agency for the Research on Cancer, there were 4.79 million cancer cases in the European region in 2020, and that number is projected to rise to 6.07 million by 2040.
Market Dynamics:
Driver:
Increasing prevalence of cancer
Cancer incidence has surged internationally, surpassing cardiovascular disease as the second greatest cause of death. Chemotherapy, the most common type of cancer treatment, is commonly coupled with other cancer medicines. Contrary to neo-adjuvant chemotherapy, which is administered prior to surgery and radiation therapy, adjuvant chemotherapy is used to reduce the tumor cell after surgery or radiation therapy. As a result, it is predicted that throughout the projected period, there will be a global increase in demand for oncology cancer medications.
Restraint:
Negative effects of drugs
Chemotherapy drugs kill healthy body cells while destroying malignant cells. This includes a number of unfavourable side effects for the individuals. Some common adverse effects include skin problems, hair loss, tiredness, neuropathies, and bone marrow suppression. A further disincentive will be the adverse effects of chemotherapy drugs, such as heart problems, low red blood cell counts, tiredness, hair loss, diarrhea, weight loss, impaired liver, kidney, and lung function, decreased bone density, and general ignorance. These are the elements limiting the market's expansion.
Opportunity:
Development of innovative technology
Chemotherapy has been essential in extending cancer patients' lives for a few more years than they otherwise would have. The most recent development in chemotherapy involves injecting drugs that treat cancer without hurting healthy cells into polluted regions. It has been demonstrated that using this technique keeps healthy tissue intact while removing cancerous cells. Using photon lasers, medical professionals may monitor the discharge of these nanoparticles into a patient's body and follow their duration and distribution while treating cancerous cells. This is the element propelling the segment's expansion.
Threat:
High associated costs
Chemotherapy is a medical procedure that uses medications to either eliminate or slow the development of cancer cells in the body. It is a typical method of treating cancer and may be used alone or in combination with other treatments. These medications target cells that divide quickly, including both cancer cells and some healthy cells. Unfortunately, as normal, healthy cells are also impacted by the treatment, this can result in a number of negative side effects. The high price of the chemotherapy drug will slow the market's expansion.
Covid-19 Impact:
The healthcare systems have been impacted by the COVID-19 pandemic, and the market has also been significantly impacted. The epidemic hampered the flow of drugs and medical supplies around the globe. This might have resulted in delays or shortages in the delivery of chemotherapy medications and other relevant medical supplies. Cancer research and clinical trials were briefly put on hold as a result of the pandemic as many institutes and pharmaceutical corporations concentrated on creating cures and vaccinations for COVID-19. This could have slowed down developments in cancer medicines like chemotherapy.
The oral segment is expected to be the largest during the forecast period
The oral segment is expected to be the largest during the forecast period. A medicine used to treat oral cancer comes in the form of a tablet, capsule, or liquid. The fastest growth rate was, however, seen with intravenous administration. Chemotherapy medications work faster because they are taken into the circulation promptly when given intravenously than when given orally or topically.
The leukemia segment is expected to have the highest CAGR during the forecast period
The leukemia segment is expected to have the highest CAGR during the forecast period. Slow-growing leukemias may require monitoring as part of their therapy. To treat severe leukemias, a combination of chemotherapy, radiation treatment, and stem cell transplantation may be employed. The rising incidence of breast cancer in women, the diversity of treatments available, and enhanced techniques for breast cancer diagnosis employing cutting-edge technology all contribute to the sector's expansion.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. Chemotherapy is increasingly being preferred over other types of treatment because of its capacity to eradicate cancer cells. The market is primarily driven by the presence of multiple chemotherapy medication producers and an increase in healthcare spending. The market is also being driven by the accessibility of healthcare facilities and the use of cutting-edge technology in the investigation and treatment of cancer.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period. It is a result of expanded government awareness initiatives and g rowing healthcare costs in this area. Due to the availability of trained and competent healthcare providers and the rising need for chemotherapy drugs, the expanding accessibility of generic pharmaceuticals will also help to slow the market's rate of progress in this area. Government cancer insurance programs are anticipated to drive market growth. Government expenditure and a rise in the incidence of cancer will thus drive the market.
Key players in the market
Some of the key players in Chemotherapy market include AstraZeneca, GlaxoSmithKline, Novartis, Bayer AG, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Schering-Plough, Eli Lilly & Company, ImClone Systems Inc., Boehringer Ingelheim, E. Hoffmann-La Roche Ltd, Merck & Co. Inc., Chemo Espana SL, CELGENE CORPORATION, Sanofi, Teva Pharmaceuticals Industries, Pfizer Inc. and Amgen Inc.
Key Developments:
In October 2023, Novartis present new data from 29 Novartis and investigator-led abstracts at the European Society for Medical Oncology (ESMO) Congress 2023, highlighting latest developments from across its oncology portfolio and addressing unmet needs of patients diagnosed with some of the most prevalent cancers, including prostate and breast.
In February 2023, Pfizer announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), demonstrating a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) compared to placebo plus XTANDI in men with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous recombination repair (HRR) gene mutations.
Drugs Covered:
• Anti-Tumor Antibiotics
• Topoisomerase Inhibitors
• Alkylating Agents
• Mitotic Inhibitors
• Antimetabolites
• Other Drugs
Route of Drugs Covered:
• Intravenous
• Oral
• Subcutaneous
• Intravascular
• Intra-Muscular
• Intraperitoneal
• Topical
• Intraventricular
Indications Covered:
• Colorectal Cancer
• Leukemia
• Prostate Cancer
• Breast Cancer
• Stomach Cancer
• Sarcoma
• Lung Cancer
• Myeloma
• Ovarian Cancer
• Lymphoma
• Other Indications
End Users Covered:
• Hospitals & Clinics
• Specialty Centers
• Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Chemotherapy Market, By Drug
5.1 Introduction
5.2 Anti-Tumor Antibiotics
5.3 Topoisomerase Inhibitors
5.4 Alkylating Agents
5.5 Mitotic Inhibitors
5.6 Antimetabolites
5.7 Other Drugs
6 Global Chemotherapy Market, By Route of Drug
6.1 Introduction
6.2 Intravenous
6.3 Oral
6.4 Subcutaneous
6.5 Intravascular
6.6 Intra-Muscular
6.7 Intraperitoneal
6.8 Topical
6.9 Intraventricular
7 Global Chemotherapy Market, By Indication
7.1 Introduction
7.2 Colorectal Cancer
7.3 Leukemia
7.4 Prostate Cancer
7.5 Breast Cancer
7.6 Stomach Cancer
7.7 Sarcoma
7.8 Lung Cancer
7.9 Myeloma
7.10 Ovarian Cancer
7.11 Lymphoma
7.12 Other Indications
8 Global Chemotherapy Market, By End User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Specialty Centers
8.4 Research Institutes
8.5 Other End Users
9 Global Chemotherapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 AstraZeneca
11.2 GlaxoSmithKline
11.3 Novartis
11.4 Bayer AG
11.5 Takeda Pharmaceutical Company Limited
11.6 Bristol-Myers Squibb
11.7 Schering-Plough
11.8 Eli Lilly & Company
11.9 ImClone Systems Inc.
11.10 Boehringer Ingelheim
11.11 E. Hoffmann-La Roche Ltd
11.12 Merck & Co. Inc.
11.13 Chemo Espana SL
11.14 CELGENE CORPORATION
11.15 Sanofi
11.16 Teva Pharmaceuticals Industries
11.17 Pfizer Inc.
11.18 Amgen Inc
List of Tables
1 Global Chemotherapy Market Outlook, By Region (2021-2030) ($MN)
2 Global Chemotherapy Market Outlook, By Drug (2021-2030) ($MN)
3 Global Chemotherapy Market Outlook, By Anti-Tumor Antibiotics (2021-2030) ($MN)
4 Global Chemotherapy Market Outlook, By Topoisomerase Inhibitors (2021-2030) ($MN)
5 Global Chemotherapy Market Outlook, By Alkylating Agents (2021-2030) ($MN)
6 Global Chemotherapy Market Outlook, By Mitotic Inhibitors (2021-2030) ($MN)
7 Global Chemotherapy Market Outlook, By Antimetabolites (2021-2030) ($MN)
8 Global Chemotherapy Market Outlook, By Other Drugs (2021-2030) ($MN)
9 Global Chemotherapy Market Outlook, By Route of Drug (2021-2030) ($MN)
10 Global Chemotherapy Market Outlook, By Intravenous (2021-2030) ($MN)
11 Global Chemotherapy Market Outlook, By Oral (2021-2030) ($MN)
12 Global Chemotherapy Market Outlook, By Subcutaneous (2021-2030) ($MN)
13 Global Chemotherapy Market Outlook, By Intravascular (2021-2030) ($MN)
14 Global Chemotherapy Market Outlook, By Intra-Muscular (2021-2030) ($MN)
15 Global Chemotherapy Market Outlook, By Intraperitoneal (2021-2030) ($MN)
16 Global Chemotherapy Market Outlook, By Topical (2021-2030) ($MN)
17 Global Chemotherapy Market Outlook, By Intraventricular (2021-2030) ($MN)
18 Global Chemotherapy Market Outlook, By Indication (2021-2030) ($MN)
19 Global Chemotherapy Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
20 Global Chemotherapy Market Outlook, By Leukemia (2021-2030) ($MN)
21 Global Chemotherapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
22 Global Chemotherapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
23 Global Chemotherapy Market Outlook, By Stomach Cancer (2021-2030) ($MN)
24 Global Chemotherapy Market Outlook, By Sarcoma (2021-2030) ($MN)
25 Global Chemotherapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
26 Global Chemotherapy Market Outlook, By Myeloma (2021-2030) ($MN)
27 Global Chemotherapy Market Outlook, By Ovarian Cancer (2021-2030) ($MN)
28 Global Chemotherapy Market Outlook, By Lymphoma (2021-2030) ($MN)
29 Global Chemotherapy Market Outlook, By Other Indications (2021-2030) ($MN)
30 Global Chemotherapy Market Outlook, By End User (2021-2030) ($MN)
31 Global Chemotherapy Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
32 Global Chemotherapy Market Outlook, By Specialty Centers (2021-2030) ($MN)
33 Global Chemotherapy Market Outlook, By Research Institutes (2021-2030) ($MN)
34 Global Chemotherapy Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.